adu-s100
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2016 (NCT02675439)
Timeline
Indications
Mechanism of action
Stimulator of interferon genes protein agonist
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4297688 ↗
Also known as
- adu-s100
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03937141 | Phase 2 | Jun 30, 2019 | Aduro BioTech |
| NCT02675439 | Phase 1 | Mar 1, 2016 | Aduro BioTech, Novartis |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aduro BioTech | For profit | 2 | 2 | 2 | 2016 |
| Novartis | For profit | 1 | 0 | 1 | 2016 |
2 organizations
Page 1 / 1